ACTB and chronic myelogenous leukemia, BCR-ABL1 positive: Western blot analysis demonstrated that the overall concentration of protein (β-actin) did not change appreciably during differentiation, indicating that the reduction in CML-modified proteins is not a reduction in overall protein modifications.